Read + Share
Amedeo Smart
Independent Medical Education
Yokoyama Y, Lew ED, Seelige R, Tindall EA, et al. Immuno-oncological Efficacy of RXDX-106, a Novel TAM (TYRO3, AXL, MER) Family Small-Molecule Kinase Inhibitor. Cancer Res 2019;79:1996-2008.PMID: 30723115
Email
LinkedIn
Facebook
Twitter
Privacy Policy